The FDA’s Upcoming Decision on Peptide Compounding Could Reshape the Telehealth Landscape
The Food and Drug Administration (FDA) is on the cusp of a decision that could significantly alter the landscape of telehealth and pharmaceutical compounding. On July 23rd and 24th, the…
